DAIICHI SANKYO CO LTD Share Price Today: Live Updates & Key Insights
DAIICHI SANKYO CO LTD share price today is $null, up null%. The stock opened at $null against the previous close of $null, with an intraday high of $null and low of $null.
DAIICHI SANKYO CO LTD Share Price Chart
DAIICHI SANKYO CO LTD
DAIICHI SANKYO CO LTD Share Price Performance
DAIICHI SANKYO CO LTD Institutional Holdings
DAIICHI SANKYO CO LTD Market Status
DAIICHI SANKYO CO LTD Fundamentals
Market Cap 30952.30 M
PB Ratio 3.0311
PE Ratio 19.7791
Enterprise Value 29234.42 M
Total Assets 4022762.05 M
Volume null
DAIICHI SANKYO CO LTD Company Financials
About DAIICHI SANKYO CO LTD & investment objective
Company Information Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally. The company offers Enhertu for the treatment of HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule for colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3, as well as symptomatic TGCT; Vanflyta, a FLT3 inhibitor for the treatment of acute myeloid leukemia; Injectafer, a ferric carboxymaltose injection for the treatment of iron deficiency; and Datroway for the treatment of HR positive and HER2 negative breast cancer, as well as NSCLC. It also provides Lixiana and Savaysa, which are direct factor Xa inhibitors; Minnebro, Olmetec, Olmetec Plus, Rezaltas, Sevikar, and Sevikar HCT, which are antihypertensive agents; Nilemdo that lowers cholesterol; Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe that reduces cholesterol; and Efient, an anti-platelet agent. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgality for the treatment of migraine attacks; Pralia for the treatment of osteoporosis and bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications and GCTB; Tarlige for the treatment of neuropathic pain; Venofer for the treatment of iron deficiency anemia; Vimpat, an anti-seizure medication; and Reyvow for the treatment of acute migraine attacks. Further, it provides Daichirona, a coronavirus RNA vaccine; Flumist, an intranasal live attenuated influenza vaccine; adsorbed cell culture-derived influenza vaccine; measles rubella combined vaccine; and mump vaccine. The company was formerly known as Sankyo Co. Ltd. and changed its name to Daiichi Sankyo Company, Limited in September 2005. Daiichi Sankyo Company, Limited was founded in 1899 and is headquartered in Chuo, Japan.
Organisation Drug Manufacturers - General
Employees 20171
Industry Drug Manufacturers - General
CEO Mr. Hiroyuki Okuzawa
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
DAIICHI SANKYO CO LTD FAQs
What is the share price of DAIICHI SANKYO CO LTD today?
The current share price of DAIICHI SANKYO CO LTD is $null.
Can I buy DAIICHI SANKYO CO LTD shares in India?
Yes, Indian investors can buy DAIICHI SANKYO CO LTD shares by opening an international trading and demat account with Motilal Oswal.
How to buy DAIICHI SANKYO CO LTD shares in India?
You can easily invest in DAIICHI SANKYO CO LTD shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy DAIICHI SANKYO CO LTD shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of DAIICHI SANKYO CO LTD.
Can I buy fractional shares of DAIICHI SANKYO CO LTD?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of DAIICHI SANKYO CO LTD?
DAIICHI SANKYO CO LTD has a market cap of $30952.30 M.
In which sector does DAIICHI SANKYO CO LTD belong?
DAIICHI SANKYO CO LTD operates in the Drug Manufacturers - General sector.
What documents are required to invest in DAIICHI SANKYO CO LTD stocks?
To invest, you typically need:
What is the PE and PB ratio of DAIICHI SANKYO CO LTD?
The PE ratio of DAIICHI SANKYO CO LTD is 19.78 and the PB ratio is 3.03.